wire - news in brief


Category



Results 251 - 300 of 382.


Astronomy / Space Science - 25.11.2019
Media conference "Launch of the CHEOPS mission"
For the time being, the Swiss space telescope CHEOPS is scheduled to begin its journey into space in mid-December on board a Soyuz rocket from the European Space Agency (ESA) in Kourou, French Guiana.

Pharmacology - Health - 25.11.2019
FDA grants priority review to Roche’s risdiplam for spinal muscular atrophy
Filing submission includes 12-month data from pivotal FIREFISH and SUNFISH trials in a broad population of people living with Types 1, 2 or 3 SMA Roche today announced that the U.S. Foo

Mathematics - Physics - 25.11.2019
The random importance of clouds
The random importance of clouds
Juhan Aru is a new professor in Mathematics at EPFL where he holds the Chair of Random Geometry. His work aims at understanding geometric properties of models where randomness and geometry meet.

Health - Pharmacology - 22.11.2019
Roche presents pivotal data demonstrating Tecentriq in combination with Avastin improves overall survival in people with the most common form of liver cancer
First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival in people with unresectable hepatocellular carcinoma compared with sorafenib Result

Event - History / Archeology - 21.11.2019

Academic Rankings - Materials Science - 20.11.2019

Chemistry - Physics - 20.11.2019
A chemist and her children
A chemist and her children
This year Renana Gershoni-Poranne was awarded a Branco Weiss Fellowship. The ETH chemist will use the research grant to design innovative compounds that can be used in future generations of electronic devices.

Materials Science - 19.11.2019
With artificial intelligence to a better wood product
With artificial intelligence to a better wood product
Empa scientist Mark Schubert and his team would like to use the many opportunities offered by machine learning for wood technology applications. Together with Swiss Wood Solutions, Schubert will present his latest project at the Swiss Innovation Forum on 21 November in Basel. Wood is a natural material that is lightweight and sustainable, with excellent physical properties, which make it an excellent choice for constructing a wide range of products with high quality requirements - for example for musical instruments and sports equipment.

Innovation - 19.11.2019
EPFL hosts a new SBB innovation unit
Swiss Federal Railways (SBB) opened a new innovation unit today at EPFL's Innovation Park, further deepening its ties with the School.

Environment - 19.11.2019

Pharmacology - Health - 18.11.2019
Roche to present new and updated data for seven approved and investigational medicines across multiple types of breast cancer at the 2019 San Antonio Breast Cancer Symposium
Study results reflect advancements in HER2-positive, triple-negative, and hormone receptor-positive breast cancer Follow-up data from pivotal phase III APHINITY study evaluating Perjeta plus Hercepti

Astronomy / Space Science - Computer Science / Telecom - 18.11.2019
Katie Bouman, the scientist who reveals the invisible
Katie Bouman, the scientist who reveals the invisible
The first-ever image of a black hole was unveiled to the public this past April. It was produced by a team of 200 scientists as part of the Event Horizon Telescope Project.

Pharmacology - Health - 17.11.2019
Novartis PARAGON-HF analyses suggest Entresto benefit beyond HFrEF
Patients & Caregivers Healthcare Professionals Society & ESG Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compare

Event - Physics - 16.11.2019

Pharmacology - Health - 15.11.2019
New Novartis medicine Adakveo (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Patients & Caregivers Healthcare Professionals Society & ESG Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications 1   Adakveo reduced the an

Pharmacology - Health - 15.11.2019
Novartis receives positive CHMP opinion for Mayzent (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS)
Patients & Caregivers Healthcare Professionals Society & ESG If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients with active seconda

Pharmacology - Health - 15.11.2019
CHMP recommends conditional EU approval of Roche’s Polivy for people with previously treated aggressive lymphoma
First-in-class antibody-drug conjugate that specifically targets CD79b, a protein expressed in the majority of B-cells Targeted off-the-shelf treatment represents potential new option for people with

Pharmacology - Health - 15.11.2019
CHMP recommends EU approval of Roche’s Kadcyla for the adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment
Kadcyla cut the risk of disease recurrence or death by half compared to Herceptin in the adjuvant setting for specific patients with HER2-positive early breast cancer At three years, 88.3% of

Event - Life Sciences - 15.11.2019

Environment - 14.11.2019
EPFL-developed geothermal panels reach international finals
EPFL-developed geothermal panels reach international finals
EPFL researchers have developed a geothermal system for recovering the heat captured in basements, subway tunnels and underground parking garages.

Mathematics - 13.11.2019

Health - Life Sciences - 13.11.2019
Award for project on Heart Transplantation
Award for project on Heart Transplantation
This year's Johanna Dürmüller-Bol DBMR Research Award of the Department for BioMedical Research (DBMR) of the University of Bern goes to Maria-Nieves Sanz.

Environment - 13.11.2019
A more sustainable material to reinforce concrete structures
A more sustainable material to reinforce concrete structures
The next generation of ultra high-performance fiber-reinforced concrete (UHPFRC) has just been created at EPFL. The new material will be used to strengthen bridges and other structures - both new and old. What's more, the process of manufacturing this material releases 60-70% less CO2 than the previous generation of fiber-reinforced concrete.

Pharmacology - Health - 12.11.2019
New Novartis PREVENT data show Cosentyx delivers early relief in axial spondyloarthritis
Patients & Caregivers Healthcare Professionals Society & ESG 42.2% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Cosentyx had improved ASAS40 scores

Health - Pharmacology - 12.11.2019
Sandoz presents real-world data showing effectiveness of Erelzi (etanercept-szzs) in rheumatic disease treatment
Patients & Caregivers Healthcare Professionals Society & ESG Interim results from COMPACT, a multi-country, real-world study of Erelzi for approved rheumatic diseases presented at 2019 ACR/AR

Business / Economics - Academic Rankings - 12.11.2019

Computer Science / Telecom - 11.11.2019
A chat with the expert: Luca Gambardella
The series of talks "Quattro chiacchiere con l'esperto", organised by USI Ideatorio Cadro, continues with Luca Gambardella, Director of Dalle Molle Institute for Artificial Intelligence USI-SUPSI. An informal chat with the expert about the human brain vs artificial intelligence.   Computer scientist Luca Gambardella is the Director of Dalle Molle Institute for Artificial Intelligence (USI-SUPSI), for which he began working in 1988.

Pharmacology - Health - 11.11.2019
Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone
NOBILITY phase II study showed 40% of patients treated with Gazyva plus standard of care achieved complete renal response at Week 76, compared to 18% of patients treated with placebo plus standard of

Pharmacology - Life Sciences - 11.11.2019
Roche’s risdiplam meets primary endpoint in pivotal SUNFISH trial in people with type 2 or 3 spinal muscular atrophy
Study demonstrated statistically significant improvements in the overall study population with Type 2 or 3 SMA No treatment related safety findings leading to withdrawal seen in any risdiplam trial t

Business / Economics - Innovation - 08.11.2019
EPFL aims to build trust in fintechs
A new research program will combine the specialist knowledge of the Swiss Finance Institute @ EPFL with insights from the School's data scientists and digital trust experts.

Business / Economics - Administration - 08.11.2019

Innovation - Computer Science / Telecom - 07.11.2019